Comparison of methotrexate dosing protocols for graft-versus-host disease prophylaxis after unrelated hematopoietic stem cell transplantation.
Nakamura N, Kanda J, Kondo T, Kitano T, Ikeda T, Imada K, Takaya R, Kubo T, Mitsuyuki S, Oka S, Yonezawa A, Takeoka T, Akasaka T, Hishizawa M, Yago K, Tsunemine H, Watanabe M, Itoh M, Takaori-Kondo A; Kyoto Stem Cell Transplantation Group (KSCTG).
Nakamura N, et al. Among authors: watanabe m.
Cytotherapy. 2024 Nov 17:S1465-3249(24)00935-6. doi: 10.1016/j.jcyt.2024.11.009. Online ahead of print.
Cytotherapy. 2024.
PMID: 39652019